Fairfax Financial (TSE:FFH – Get Free Report) had its price objective hoisted by equities research analysts at National Bankshares from C$2,000.00 to C$2,100.00 in a research note issued to investors on Tuesday, BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. National Bankshares’ price objective suggests a potential upside of 40.09% from the stock’s previous close.
Several other research firms have also weighed in on FFH. Cormark lifted their price target on Fairfax Financial from C$1,600.00 to C$1,800.00 in a research report on Thursday, April 18th. Scotiabank raised their price objective on Fairfax Financial from C$1,900.00 to C$2,000.00 in a research report on Friday. BMO Capital Markets raised their price objective on Fairfax Financial from C$1,550.00 to C$1,650.00 and gave the company an “outperform” rating in a research report on Tuesday, February 20th. Royal Bank of Canada raised their price objective on Fairfax Financial from C$1,085.00 to C$1,200.00 and gave the company an “outperform” rating in a research report on Tuesday, February 20th. Finally, CIBC raised their price objective on Fairfax Financial from C$1,700.00 to C$2,000.00 in a research report on Wednesday, March 13th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of C$1,791.67.
Check Out Our Latest Report on FFH
Fairfax Financial Trading Down 0.6 %
Fairfax Financial (TSE:FFH – Get Free Report) last announced its quarterly earnings results on Thursday, February 15th. The company reported C$71.98 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C$81.40 by C($9.42). Fairfax Financial had a net margin of 13.76% and a return on equity of 20.09%. The business had revenue of C$9.40 billion for the quarter, compared to analysts’ expectations of C$10.25 billion. On average, sell-side analysts predict that Fairfax Financial will post 189.55125 earnings per share for the current year.
Insider Activity
In related news, Director Christine N. Mclean purchased 80 shares of Fairfax Financial stock in a transaction dated Wednesday, February 21st. The stock was purchased at an average cost of C$1,349.98 per share, for a total transaction of C$107,998.40. Following the completion of the acquisition, the director now directly owns 589 shares of the company’s stock, valued at C$795,138.22. In other Fairfax Financial news, Director Christine N. Mclean acquired 80 shares of Fairfax Financial stock in a transaction that occurred on Wednesday, February 21st. The stock was bought at an average cost of C$1,349.98 per share, for a total transaction of C$107,998.40. Following the acquisition, the director now owns 589 shares of the company’s stock, valued at C$795,138.22. Also, Director Brian Johnston Porter acquired 100 shares of Fairfax Financial stock in a transaction that occurred on Thursday, March 14th. The stock was acquired at an average price of C$1,509.40 per share, with a total value of C$150,940.00. Following the completion of the acquisition, the director now directly owns 950 shares in the company, valued at approximately C$1,433,930. Over the last three months, insiders purchased 190 shares of company stock worth $273,877 and sold 4,572 shares worth $5,835,859. Corporate insiders own 3.63% of the company’s stock.
About Fairfax Financial
Fairfax Financial Holdings Limited, through its subsidiaries, provides property and casualty insurance and reinsurance, and investment management services in the United States, Canada, Asia, and internationally. The company operates through Property and Casualty Insurance and Reinsurance, Life insurance and Run-off, and Non-Insurance Companies segments.
See Also
- Five stocks we like better than Fairfax Financial
- The How and Why of Investing in Biotech Stocks
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- How to Invest in Small Cap StocksĀ
- Hilton Demonstrates Asset Light is Right for Investors
- Stock Market Upgrades: What Are They?
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Fairfax Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fairfax Financial and related companies with MarketBeat.com's FREE daily email newsletter.